FDA clears Wandercraft's exoskeleton for stroke patient rehab
Stroke patients in the US could soon take advantage of cutting-edge robotics during the recovery process. The Food and Drug Administration has cleared Wandercraft'sfor use in stroke rehabilitation. The machine can help with intensive gait training, particularly for people with limited upper body mobility that might prevent using other methods.
The current-generation Atalante is a self-balancing, battery-powered device with an adjustable gait that can help with early steps through to more natural walking later in therapy. While the hardware still needs to be used in a clinical setting with help from a therapist, its hands-free use lets patients reestablish their gait whether or not they can use their arms.
Wandercraft plans to deliver its first exoskeletons to the US during the first quarter of the year, though it didn't name initial customers. It only recently launched its commercial business in the country, but financial backer Quadrant Management says Wandercraft could"significantly scale" its operations within the next one to two years.You can disable notifications at any time in your settings menu.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Elon Musk defends 'funding secured' tweets in Tesla shareholder trial | EngadgetElon Musk said that just because he tweets something, it 'does not mean people believe it or will act accordingly.'.
Consulte Mais informação »
Google lays off most employees part of its Area 120 incubator | EngadgetAlphabet recently admitted that it's cutting 12,000 jobs, which is around six percent of its global workforce..
Consulte Mais informação »
‘Marvel’s Avengers’ won’t receive official support after September 30th | EngadgetCrystal Dynamics confirmed on Friday it would discontinue support for Marvel's Avengers later this year..
Consulte Mais informação »
Twitter is working on an ad-free subscription tier | EngadgetTwitter is working on a new, more expensive Blue subscription tier that will allow users to browse the platform without seeing ads, according to Elon Musk..
Consulte Mais informação »
FTC asks court to hold Martin Shkreli in contempt for launching new drug company | EngadgetUS District Court Judge Denise Cote imposed a lifetime ban on Shkreli that prohibits him from participating in the pharmaceutical industry early last year..
Consulte Mais informação »